"Official View" on Glucocorticoids in Rheumatoid Arthritis: A Systematic Review of International Guidelines and Consensus Statements

scientific article published on 28 December 2016

"Official View" on Glucocorticoids in Rheumatoid Arthritis: A Systematic Review of International Guidelines and Consensus Statements is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ACR.23185
P698PubMed publication ID28029750

P50authorFrank ButtgereitQ47265901
P2093author name stringEric L Matteson
Maarten Boers
Christian Dejaco
Johannes W Bijlsma
Marieke Voshaar
Thomas Buttgereit
Yannick Palmowski
P2860cites workDisease status, costs and quality of life of patients with rheumatoid arthritis in France: the ECO-PR Study.Q51703776
[EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases].Q52913362
Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.Q53187237
AGREE II: Advancing guideline development, reporting, and evaluation in health careQ56637210
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisQ57245378
Glucocorticoids and chronotherapy in rheumatoid arthritisQ26752725
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateQ26859134
2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiativeQ28081356
The timing of prednisolone dosage and its effect on morning stiffness in rheumatoid arthritisQ33555511
SMALL DOSES OF PREDNISOLONE IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS.Q33579593
A non-inferiority trial of an attenuated combination strategy ('COBRA-light') compared to the original COBRA strategy: clinical results after 26 weeksQ33659050
Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of RheumatologyQ34641300
Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximabQ34658023
The timing of glucocorticoid administration in rheumatoid arthritisQ35546903
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatologyQ35551818
APLAR rheumatoid arthritis treatment recommendations.Q35762912
The importance of assessment and management of morning stiffness in Asian patients with rheumatoid arthritis: Recommendations from an expert panelQ35786849
Half of U.K. patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: a retrospective drug utilisation studyQ36477420
Opioid use in patients with rheumatoid arthritis 2005-2014: a population-based comparative study.Q36850752
Practice guidelines for pharmacists: The pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugsQ37654774
Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugsQ37932896
Glucocorticoids in rheumatoid arthritis.Q38075503
German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugsQ38128726
Update of the Mexican College of Rheumatology guidelines for the pharmacologic treatment of rheumatoid arthritisQ38170855
Recommendations of the French Society for Rheumatology for managing rheumatoid arthritisQ38225477
Adding a "GRADE" to the quality appraisal of rheumatoid arthritis guidelines identifies limitations beyond AGREE-II.Q38252853
Clocking in: chronobiology in rheumatoid arthritisQ38387724
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task forceQ38757421
Drug prescribing trends in adults with rheumatoid arthritis: a population-based comparative study from 2005 to 2014.Q39662558
Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry StudyQ41728784
The burden of rheumatoid arthritis and access to treatment: health burden and costsQ46256192
South African recommendations for the management of rheumatoid arthritis: an algorithm for the standard of care in 2013.Q46648627
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectrheumatoid arthritisQ187255
P304page(s)1134-1141
P577publication date2016-12-28
P1433published inArthritis Care and ResearchQ15754720
P1476title"Official View" on Glucocorticoids in Rheumatoid Arthritis: A Systematic Review of International Guidelines and Consensus Statements
P478volume69

Reverse relations

cites work (P2860)
Q92106947A General Introduction to Glucocorticoid Biology
Q90354326A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis - results of clinical relevance
Q54246292Comorbidities in Spondyloarthritis.
Q92848480Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements
Q64958091Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study.
Q64889511Impact of Cumulative Corticosteroid Dosage on Preventable Hospitalization among Taiwanese Patients with Ankylosing Spondylitis and Inflammatory Bowel Disease.
Q61449138Increased Risk of Thyroid Dysfunction Among Patients With Rheumatoid Arthritis
Q90415241Long-term treatment with low dose glucocorticoids in Rheumatoid Arthritis: New tricks of an old drug
Q89458696Management of inflammatory rheumatic conditions in the elderly

Search more.